Literature DB >> 26095378

Classification of Peptides According to their Blood-Brain Barrier Influx.

Sofie Stalmans, Bert Gevaert, Evelien Wynendaele, Joachim Nielandt, Guy De Tre, Kathelijne Peremans, Christian Burvenich, Bart De Spiegeleer1.   

Abstract

An increasing number of studies demonstrate the ability of peptides to cross the blood-brain barrier (BBB), opening perspectives for a new class of therapeutics for central nervous system diseases. However, information on the BBB transport of peptides suffer from a wide variety in used methods and experimental set-up. Therefore, it is currently difficult, if not impossible, to classify peptides according to their BBB influx characteristics. To allow direct comparison of BBB influx results of peptides, we introduce a classification method and unified response for BBB influx transport of peptides. First, the results of BBB influx response types (i.e. Kin (MTR), Kin (Perfusion), Pin vitro and Pin vivo), which quantitatively express brain influx, were classified into five classes of BBB influx magnitude based on the distribution of these results for the individual response types. Then, these classes were converted to a BBBin-response, representing a scaled value ranging from zero (no influx) to ten (high influx), independent from the BBB influx response type from which it was derived. This unified response can immediately be applied for new BBB influx results of peptides and represents a ballpark figure for BBB influx and allows direct comparison and ranking of peptides independent of the response type.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26095378     DOI: 10.2174/0929866522666150622101223

Source DB:  PubMed          Journal:  Protein Pept Lett        ISSN: 0929-8665            Impact factor:   1.890


  6 in total

1.  Quantitative In Vitro and In Vivo Evaluation of Intestinal and Blood-Brain Barrier Transport Kinetics of the Plant N-Alkylamide Pellitorine.

Authors:  Lieselotte Veryser; Nathalie Bracke; Evelien Wynendaele; Tanmayee Joshi; Pratima Tatke; Lien Taevernier; Bart De Spiegeleer
Journal:  Biomed Res Int       Date:  2016-07-04       Impact factor: 3.411

2.  Cell-Penetrating Peptides Selectively Cross the Blood-Brain Barrier In Vivo.

Authors:  Sofie Stalmans; Nathalie Bracke; Evelien Wynendaele; Bert Gevaert; Kathelijne Peremans; Christian Burvenich; Ingeborgh Polis; Bart De Spiegeleer
Journal:  PLoS One       Date:  2015-10-14       Impact factor: 3.240

3.  Topics and trends in artificial intelligence assisted human brain research.

Authors:  Xieling Chen; Juan Chen; Gary Cheng; Tao Gong
Journal:  PLoS One       Date:  2020-04-06       Impact factor: 3.240

4.  PapRIV, a BV-2 microglial cell activating quorum sensing peptide.

Authors:  Yorick Janssens; Nathan Debunne; Anton De Spiegeleer; Evelien Wynendaele; Marta Planas; Lidia Feliu; Alessandra Quarta; Christel Claes; Debby Van Dam; Peter Paul De Deyn; Peter Ponsaerts; Matthew Blurton-Jones; Bart De Spiegeleer
Journal:  Sci Rep       Date:  2021-05-21       Impact factor: 4.379

5.  Quorum Sensing Peptides Selectively Penetrate the Blood-Brain Barrier.

Authors:  Evelien Wynendaele; Frederick Verbeke; Sofie Stalmans; Bert Gevaert; Yorick Janssens; Christophe Van De Wiele; Kathelijne Peremans; Christian Burvenich; Bart De Spiegeleer
Journal:  PLoS One       Date:  2015-11-04       Impact factor: 3.240

6.  Mucosal and blood-brain barrier transport kinetics of the plant N-alkylamide spilanthol using in vitro and in vivo models.

Authors:  Lieselotte Veryser; Lien Taevernier; Tanmayee Joshi; Pratima Tatke; Evelien Wynendaele; Nathalie Bracke; Sofie Stalmans; Kathelijne Peremans; Christian Burvenich; Martijn Risseeuw; Bart De Spiegeleer
Journal:  BMC Complement Altern Med       Date:  2016-06-13       Impact factor: 3.659

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.